메뉴 건너뛰기




Volumn 66, Issue 10, 2013, Pages 1105-1117.e1

Interrater reliability of grading strength of evidence varies with the complexity of the evidence in systematic reviews

Author keywords

Agency for Healthcare Research and Quality; Comparative effectiveness; Evidence based practice; Interrater reliability; Strength of evidence; Systematic review methodology

Indexed keywords

ARTICLE; HEALTH PROGRAM; HUMAN; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MEASUREMENT PRECISION; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; SYSTEMATIC REVIEW (TOPIC);

EID: 84883355019     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.06.002     Document Type: Article
Times cited : (23)

References (55)
  • 2
    • 0032191668 scopus 로고    scopus 로고
    • Health policy issues and applications for evidence-based medicine and clinical practice guidelines
    • K.N. Lohr, K. Eleazer, and J. Mauskopf Health policy issues and applications for evidence-based medicine and clinical practice guidelines Health Policy 46 1 1998 1 19
    • (1998) Health Policy , vol.46 , Issue.1 , pp. 1-19
    • Lohr, K.N.1    Eleazer, K.2    Mauskopf, J.3
  • 3
    • 1242330428 scopus 로고    scopus 로고
    • Rating the strength of scientific evidence: Relevance for quality improvement programs
    • K.N. Lohr Rating the strength of scientific evidence: relevance for quality improvement programs Int J Qual Health Care 16 1 2004 9 18
    • (2004) Int J Qual Health Care , vol.16 , Issue.1 , pp. 9-18
    • Lohr, K.N.1
  • 7
    • 84883341737 scopus 로고    scopus 로고
    • Cochrane Collaboration [Accessed July 3, 2012]
    • Cochrane Collaboration. Evidence Aid project. Available at http://www.cochrane.org/cochrane-reviews/evidence-aid-project. [Accessed July 3, 2012].
    • Evidence Aid Project
  • 8
    • 0035318124 scopus 로고    scopus 로고
    • Current methods of the US Preventive Services Task Force: A review of the process
    • R.P. Harris, M. Helfand, S.H. Woolf, K.N. Lohr, C.D. Mulrow, and S.M. Teutsch Current methods of the US Preventive Services Task Force: a review of the process Am J Prev Med 20 3 Suppl 2001 21 35
    • (2001) Am J Prev Med , vol.20 , Issue.3 SUPPL. , pp. 21-35
    • Harris, R.P.1    Helfand, M.2    Woolf, S.H.3    Lohr, K.N.4    Mulrow, C.D.5    Teutsch, S.M.6
  • 9
    • 20544463475 scopus 로고    scopus 로고
    • Challenges of summarizing better information for better health: The Evidence-based Practice Center experience. A guide to this supplement
    • M. Helfand, S. Morton, E. Guallar, and C. Mulrow Challenges of summarizing better information for better health: the Evidence-based Practice Center experience. A guide to this supplement Ann Intern Med 142 12 Pt 2 2005 1033 1034
    • (2005) Ann Intern Med , vol.142 , Issue.12 PART 2 , pp. 1033-1034
    • Helfand, M.1    Morton, S.2    Guallar, E.3    Mulrow, C.4
  • 11
    • 33748550986 scopus 로고    scopus 로고
    • A simple and valid tool distinguished efficacy from effectiveness studies
    • G. Gartlehner, R.A. Hansen, D. Nissman, K.N. Lohr, and T.S. Carey A simple and valid tool distinguished efficacy from effectiveness studies J Clin Epidemiol 59 2006 1040 1048
    • (2006) J Clin Epidemiol , vol.59 , pp. 1040-1048
    • Gartlehner, G.1    Hansen, R.A.2    Nissman, D.3    Lohr, K.N.4    Carey, T.S.5
  • 12
    • 84859044068 scopus 로고    scopus 로고
    • Clinical heterogeneity in systematic reviews and health technology assessments: Synthesis of guidance documents and the literature
    • G. Gartlehner, S.L. West, A.J. Mansfield, C. Poole, E. Tant, and L.J. Lux Clinical heterogeneity in systematic reviews and health technology assessments: synthesis of guidance documents and the literature Int J Technol Assess Health Care 28 2012 36 43
    • (2012) Int J Technol Assess Health Care , vol.28 , pp. 36-43
    • Gartlehner, G.1    West, S.L.2    Mansfield, A.J.3    Poole, C.4    Tant, E.5    Lux, L.J.6
  • 13
    • 77949778981 scopus 로고    scopus 로고
    • Agency for Healthcare Research and Quality [Accessed June 22, 2011]
    • Agency for Healthcare Research and Quality. Methods guide for effectiveness and comparative effectiveness reviews. 2008. Available at http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productid=318. [Accessed June 22, 2011].
    • (2008) Methods Guide for Effectiveness and Comparative Effectiveness Reviews
  • 14
    • 0033194558 scopus 로고    scopus 로고
    • Assessing "best evidence": Issues in grading the quality of studies for systematic reviews
    • K.N. Lohr, and T.S. Carey Assessing "best evidence": issues in grading the quality of studies for systematic reviews Jt Comm J Qual Improv 25 9 1999 470 479
    • (1999) Jt Comm J Qual Improv , vol.25 , Issue.9 , pp. 470-479
    • Lohr, K.N.1    Carey, T.S.2
  • 16
    • 20044382229 scopus 로고    scopus 로고
    • Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches the GRADE Working Group
    • D. Atkins, M. Eccles, S. Flottorp, G.H. Guyatt, D. Henry, and S. Hill Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE Working Group BMC Health Serv Res 4 1 2004 38
    • (2004) BMC Health Serv Res , vol.4 , Issue.1 , pp. 38
    • Atkins, D.1    Eccles, M.2    Flottorp, S.3    Guyatt, G.H.4    Henry, D.5    Hill, S.6
  • 17
    • 43249093669 scopus 로고    scopus 로고
    • What is "quality of evidence" and why is it important to clinicians?
    • [Review]
    • G.H. Guyatt, A.D. Oxman, R. Kunz, G.E. Vist, Y. Falck-Ytter, and H.J. Schunemann What is "quality of evidence" and why is it important to clinicians? BMJ 336 2008 995 998 [Review]
    • (2008) BMJ , vol.336 , pp. 995-998
    • Guyatt, G.H.1    Oxman, A.D.2    Kunz, R.3    Vist, G.E.4    Falck-Ytter, Y.5    Schunemann, H.J.6
  • 18
    • 77949609822 scopus 로고    scopus 로고
    • AHRQ series paper 5: Grading the strength of a body of evidence when comparing medical interventions - Agency for healthcare research and quality and the effective health-care program
    • D.K. Owens, K.N. Lohr, D. Atkins, J.R. Treadwell, J.T. Reston, and E.B. Bass AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions - agency for healthcare research and quality and the effective health-care program J Clin Epidemiol 63 2010 513 523
    • (2010) J Clin Epidemiol , vol.63 , pp. 513-523
    • Owens, D.K.1    Lohr, K.N.2    Atkins, D.3    Treadwell, J.R.4    Reston, J.T.5    Bass, E.B.6
  • 19
    • 84883359030 scopus 로고    scopus 로고
    • Training Modules for Systematic Reviews Methods Guide Rockville, MD
    • K.N. Lohr Grading strength of evidence 2011 Training Modules for Systematic Reviews Methods Guide Rockville, MD
    • (2011) Grading Strength of Evidence
    • Lohr, K.N.1
  • 23
    • 19444362507 scopus 로고    scopus 로고
    • Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system
    • D. Atkins, P.A. Briss, M. Eccles, S. Flottorp, G.H. Guyatt, and R.T. Harbour Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system BMC Health Serv Res 5 1 2005 25
    • (2005) BMC Health Serv Res , vol.5 , Issue.1 , pp. 25
    • Atkins, D.1    Briss, P.A.2    Eccles, M.3    Flottorp, S.4    Guyatt, G.H.5    Harbour, R.T.6
  • 27
    • 0025286295 scopus 로고
    • High agreement but low kappa: 1. The problems of two paradoxes
    • A.R. Feinstein, and D.V. Chicchetti High agreement but low kappa: 1. The problems of two paradoxes J Clin Epidemiol 43 1990 543 549
    • (1990) J Clin Epidemiol , vol.43 , pp. 543-549
    • Feinstein, A.R.1    Chicchetti, D.V.2
  • 28
    • 0017360990 scopus 로고
    • The measurement of observer agreement for categorical data
    • J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
    • (1977) Biometrics , vol.33 , pp. 159-174
    • Landis, J.R.1    Koch, G.G.2
  • 29
    • 18544372466 scopus 로고    scopus 로고
    • Understanding interobserver agreement: The kappa statistic
    • A.J. Viera, and J.M. Garrett Understanding interobserver agreement: the kappa statistic Fam Med 37 5 2005 360 363
    • (2005) Fam Med , vol.37 , Issue.5 , pp. 360-363
    • Viera, A.J.1    Garrett, J.M.2
  • 30
    • 84883378299 scopus 로고    scopus 로고
    • SUDAAN Research Triangle Institute Research Triangle Institute Research Triangle Park, NC
    • SUDAAN Research Triangle Institute SUDAAN user's manual, release 10.0.1 2009 Research Triangle Institute Research Triangle Park, NC
    • (2009) SUDAAN User's Manual, Release 10.0.1
  • 31
    • 0033061679 scopus 로고    scopus 로고
    • A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
    • G. Chouinard, B. Saxena, M.C. Belanger, A. Ravindran, D. Bakish, and L. Beauclair A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder J Affect Disord 54 1-2 1999 39 48
    • (1999) J Affect Disord , vol.54 , Issue.12 , pp. 39-48
    • Chouinard, G.1    Saxena, B.2    Belanger, M.C.3    Ravindran, A.4    Bakish, D.5    Beauclair, L.6
  • 32
    • 0027405498 scopus 로고
    • A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients
    • J. De Wilde, R. Spiers, C. Mertens, F. Bartholome, G. Schotte, and S. Leyman A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients Acta Psychiatr Scand 87 2 1993 141 145
    • (1993) Acta Psychiatr Scand , vol.87 , Issue.2 , pp. 141-145
    • De Wilde, J.1    Spiers, R.2    Mertens, C.3    Bartholome, F.4    Schotte, G.5    Leyman, S.6
  • 33
    • 0032463647 scopus 로고    scopus 로고
    • A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression
    • M. Fava, J.D. Amsterdam, J.A. Deltito, C. Salzman, M. Schwaller, and D.L. Dunner A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression Ann Clin Psychiatry 10 4 1998 145 150
    • (1998) Ann Clin Psychiatry , vol.10 , Issue.4 , pp. 145-150
    • Fava, M.1    Amsterdam, J.D.2    Deltito, J.A.3    Salzman, C.4    Schwaller, M.5    Dunner, D.L.6
  • 34
    • 0036219227 scopus 로고    scopus 로고
    • Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia
    • M. Fava, S.L. Hoog, R.A. Judge, J.B. Kopp, M.E. Nilsson, and J.S. Gonzales Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia J Clin Psychopharmacol 22 2 2002 137 147
    • (2002) J Clin Psychopharmacol , vol.22 , Issue.2 , pp. 137-147
    • Fava, M.1    Hoog, S.L.2    Judge, R.A.3    Kopp, J.B.4    Nilsson, M.E.5    Gonzales, J.S.6
  • 35
    • 0027857154 scopus 로고
    • A double blind comparison of paroxetine and fluoxetine in patients with major depression
    • C.A. Gagiano A double blind comparison of paroxetine and fluoxetine in patients with major depression Br J Clin Res 4 1993 145 152
    • (1993) Br J Clin Res , vol.4 , pp. 145-152
    • Gagiano, C.A.1
  • 36
    • 0027764277 scopus 로고
    • A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression
    • W. Schone, and M. Ludwig A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression J Clin Psychopharmacol 13 6 Suppl 2 1993 34S 39S
    • (1993) J Clin Psychopharmacol , vol.13 , Issue.6 SUPPL. 2
    • Schone, W.1    Ludwig, M.2
  • 37
    • 0035915312 scopus 로고    scopus 로고
    • Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial
    • K. Kroenke, S.L. West, R. Swindle, A. Gilsenan, G.J. Eckert, and R. Dolor Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial JAMA 286 2001 2947 2955
    • (2001) JAMA , vol.286 , pp. 2947-2955
    • Kroenke, K.1    West, S.L.2    Swindle, R.3    Gilsenan, A.4    Eckert, G.J.5    Dolor, R.6
  • 39
    • 0035108671 scopus 로고    scopus 로고
    • Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction
    • A.L. Montejo, G. Llorca, J.A. Izquierdo, and F. Rico-Villademoros Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction J Clin Psychiatry 62 Suppl 3 2001 10 21
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 3 , pp. 10-21
    • Montejo, A.L.1    Llorca, G.2    Izquierdo, J.A.3    Rico-Villademoros, F.4
  • 40
    • 3142735110 scopus 로고    scopus 로고
    • Antidepressants and the risk of suicidal behaviors
    • H. Jick, J.A. Kaye, and S.S. Jick Antidepressants and the risk of suicidal behaviors JAMA 292 2004 338 343
    • (2004) JAMA , vol.292 , pp. 338-343
    • Jick, H.1    Kaye, J.A.2    Jick, S.S.3
  • 41
    • 19744382704 scopus 로고    scopus 로고
    • Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: Nested case-control study
    • C. Martinez, S. Rietbrock, L. Wise, D. Ashby, J. Chick, and J. Moseley Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study BMJ 330 2005 389
    • (2005) BMJ , vol.330 , pp. 389
    • Martinez, C.1    Rietbrock, S.2    Wise, L.3    Ashby, D.4    Chick, J.5    Moseley, J.6
  • 43
    • 31044442965 scopus 로고    scopus 로고
    • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    • F.C. Breedveld, M.H. Weisman, A.F. Kavanaugh, S.B. Cohen, K. Pavelka, and R. van Vollenhoven The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 2006 26 37
    • (2006) Arthritis Rheum , vol.54 , pp. 26-37
    • Breedveld, F.C.1    Weisman, M.H.2    Kavanaugh, A.F.3    Cohen, S.B.4    Pavelka, K.5    Van Vollenhoven, R.6
  • 44
    • 33750372498 scopus 로고    scopus 로고
    • Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: A double-blind comparison
    • B.G. Combe, C. Codreanu, U. Fiocco, M. Gaubitz, P.P. Geusens, and T.K. Kvien Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison Ann Rheum Dis 65 2006 1357 1362
    • (2006) Ann Rheum Dis , vol.65 , pp. 1357-1362
    • Combe, B.G.1    Codreanu, C.2    Fiocco, U.3    Gaubitz, M.4    Geusens, P.P.5    Kvien, T.K.6
  • 46
    • 10744223002 scopus 로고    scopus 로고
    • Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial
    • L. Klareskog, D. van der Heijde, J.P. de Jager, A. Gough, J. Kalden, and M. Malaise Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial Lancet 363 2004 675 681
    • (2004) Lancet , vol.363 , pp. 675-681
    • Klareskog, L.1    Van Der Heijde, D.2    De Jager, J.P.3    Gough, A.4    Kalden, J.5    Malaise, M.6
  • 47
    • 0036201509 scopus 로고    scopus 로고
    • Health-related quality of life in early rheumatoid arthritis: Impact of disease and treatment response
    • M. Kosinski, S.C. Kujawski, R. Martin, L.A. Wanke, M.C. Buatti, and J.E. Ware Jr. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response Am J Manag Care 8 3 2002 231 240
    • (2002) Am J Manag Care , vol.8 , Issue.3 , pp. 231-240
    • Kosinski, M.1    Kujawski, S.C.2    Martin, R.3    Wanke, L.A.4    Buatti, M.C.5    Ware, Jr.J.E.6
  • 48
    • 27444447706 scopus 로고    scopus 로고
    • Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results
    • D. van der Heijde, L. Klareskog, M. Boers, R. Landewe, C. Codreanu, and H.D. Bolosiu Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results Ann Rheum Dis 64 11 2005 1582 1587
    • (2005) Ann Rheum Dis , vol.64 , Issue.11 , pp. 1582-1587
    • Van Der Heijde, D.1    Klareskog, L.2    Boers, M.3    Landewe, R.4    Codreanu, C.5    Bolosiu, H.D.6
  • 49
    • 33646365588 scopus 로고    scopus 로고
    • Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial
    • D. van der Heijde, L. Klareskog, V. Rodriguez-Valverde, C. Codreanu, H. Bolosiu, and J. Melo-Gomes Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial Arthritis Rheum 54 2006 1063 1074
    • (2006) Arthritis Rheum , vol.54 , pp. 1063-1074
    • Van Der Heijde, D.1    Klareskog, L.2    Rodriguez-Valverde, V.3    Codreanu, C.4    Bolosiu, H.5    Melo-Gomes, J.6
  • 50
    • 33144458951 scopus 로고    scopus 로고
    • Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: The TEMPO trial
    • D. van der Heijde, L. Klareskog, A. Singh, J. Tornero, J. Melo-Gomes, and C. Codreanu Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial Ann Rheum Dis 65 3 2006 328 334
    • (2006) Ann Rheum Dis , vol.65 , Issue.3 , pp. 328-334
    • Van Der Heijde, D.1    Klareskog, L.2    Singh, A.3    Tornero, J.4    Melo-Gomes, J.5    Codreanu, C.6
  • 51
    • 0036720662 scopus 로고    scopus 로고
    • Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: Clinical experience using a structured follow up programme in southern Sweden
    • P. Geborek, M. Crnkic, I.F. Petersson, and T. Saxne Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden Ann Rheum Dis 61 9 2002 793 798
    • (2002) Ann Rheum Dis , vol.61 , Issue.9 , pp. 793-798
    • Geborek, P.1    Crnkic, M.2    Petersson, I.F.3    Saxne, T.4
  • 52
    • 30844434332 scopus 로고    scopus 로고
    • Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: Results from the RADIUS observational registry
    • A.L. Weaver, R.L. Lautzenheiser, M.H. Schiff, A. Gibofsky, J.L. Perruquet, and J. Luetkemeyer Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry Curr Med Res Opin 22 1 2006 185 198
    • (2006) Curr Med Res Opin , vol.22 , Issue.1 , pp. 185-198
    • Weaver, A.L.1    Lautzenheiser, R.L.2    Schiff, M.H.3    Gibofsky, A.4    Perruquet, J.L.5    Luetkemeyer, J.6
  • 53
    • 70350554084 scopus 로고    scopus 로고
    • Clinical and functional remission: Even though biologics are superior to conventional DMARDs overall success rates remain low - Results from RABBIT, the German biologics register
    • J. Listing, A. Strangfeld, R. Rau, J. Kekow, E. Gromnica-Ihle, and T. Klopsch Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low - results from RABBIT, the German biologics register Arthritis Res Ther 8 3 2006 R66
    • (2006) Arthritis Res Ther , vol.8 , Issue.3 , pp. 66
    • Listing, J.1    Strangfeld, A.2    Rau, R.3    Kekow, J.4    Gromnica-Ihle, E.5    Klopsch, T.6
  • 54
    • 34247218183 scopus 로고    scopus 로고
    • Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists
    • J.R. Curtis, N. Patkar, A. Xie, C. Martin, J.J. Allison, and M. Saag Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists Arthritis Rheum 56 2007 1125 1133
    • (2007) Arthritis Rheum , vol.56 , pp. 1125-1133
    • Curtis, J.R.1    Patkar, N.2    Xie, A.3    Martin, C.4    Allison, J.J.5    Saag, M.6
  • 55
    • 34447521875 scopus 로고    scopus 로고
    • Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
    • S. Schneeweiss, S. Setoguchi, M.E. Weinblatt, J.N. Katz, J. Avorn, and P.E. Sax Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis Arthritis Rheum 56 2007 1754 1764
    • (2007) Arthritis Rheum , vol.56 , pp. 1754-1764
    • Schneeweiss, S.1    Setoguchi, S.2    Weinblatt, M.E.3    Katz, J.N.4    Avorn, J.5    Sax, P.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.